Bupivacaine and botulinum toxin to treat comitant strabismus

Detalhes bibliográficos
Autor(a) principal: Hopker,Luisa Moreira
Data de Publicação: 2012
Outros Autores: Zaupa,Priscila Fernandes, Lima Filho,Acácio Alves de Souza, Cronemberger,Monica Fialho, Tabuse,Marcia Keiko Uyeno, Nakanami,Célia Regina, Allemann,Norma, Mendonça,Tomás Scalamandré
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos brasileiros de oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008
Resumo: PURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection of 2 ml of 1.5% bupivacaine and 2.5 U of botulinum toxin A in agonist and antagonist muscles, respectively, of eight amblyopic eyes. Muscle thickness was measured prior and on days 1, 7 and 30 after injection using 10-MHz ultrasonography (eyelid technique). RESULTS: Mean change in alignment was 10 prism diopters after 180 days (n=6). An average increase of 1.01 mm in muscle thickness was observed after 30 days of bupivacaine injection and 0.28 mm increase was observed after botulinum toxin A injection, as measured by ultrasonography. Lateral rectus muscles injected with bupivacaine had a mean increase of 1.5 mm in muscle thickness. CONCLUSION: In this study, a change in ocular motility was observed after 180 days of intramuscular injection of bupivacaine and botulinum toxin in horizontal extraocular muscles. Overall, there was an increase of muscle thickness in both botulinum toxinum A and bupivacaine injected muscles after 30 days of injection when measured by ultrasonography. This change was more pronounced on lateral rectus muscles after bupivacaine injection.
id CBO-2_fba9c341856eff26d2af4afc17b8af24
oai_identifier_str oai:scielo:S0004-27492012000200008
network_acronym_str CBO-2
network_name_str Arquivos brasileiros de oftalmologia (Online)
repository_id_str
spelling Bupivacaine and botulinum toxin to treat comitant strabismusOculomotor musclesStrabismus/diagnosisStrabismus/drug therapyEsotropia/drug therapyBotulinium toxins, type A/administration & dosageBotulinium toxins, type A/therapeutic useBupivacaine/therapeutic useBupivacaine/administration & dosageInjections,intramuscularUltrasonographyPURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection of 2 ml of 1.5% bupivacaine and 2.5 U of botulinum toxin A in agonist and antagonist muscles, respectively, of eight amblyopic eyes. Muscle thickness was measured prior and on days 1, 7 and 30 after injection using 10-MHz ultrasonography (eyelid technique). RESULTS: Mean change in alignment was 10 prism diopters after 180 days (n=6). An average increase of 1.01 mm in muscle thickness was observed after 30 days of bupivacaine injection and 0.28 mm increase was observed after botulinum toxin A injection, as measured by ultrasonography. Lateral rectus muscles injected with bupivacaine had a mean increase of 1.5 mm in muscle thickness. CONCLUSION: In this study, a change in ocular motility was observed after 180 days of intramuscular injection of bupivacaine and botulinum toxin in horizontal extraocular muscles. Overall, there was an increase of muscle thickness in both botulinum toxinum A and bupivacaine injected muscles after 30 days of injection when measured by ultrasonography. This change was more pronounced on lateral rectus muscles after bupivacaine injection.Conselho Brasileiro de Oftalmologia2012-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008Arquivos Brasileiros de Oftalmologia v.75 n.2 2012reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.1590/S0004-27492012000200008info:eu-repo/semantics/openAccessHopker,Luisa MoreiraZaupa,Priscila FernandesLima Filho,Acácio Alves de SouzaCronemberger,Monica FialhoTabuse,Marcia Keiko UyenoNakanami,Célia ReginaAllemann,NormaMendonça,Tomás Scalamandréeng2012-06-15T00:00:00Zoai:scielo:S0004-27492012000200008Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2012-06-15T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false
dc.title.none.fl_str_mv Bupivacaine and botulinum toxin to treat comitant strabismus
title Bupivacaine and botulinum toxin to treat comitant strabismus
spellingShingle Bupivacaine and botulinum toxin to treat comitant strabismus
Hopker,Luisa Moreira
Oculomotor muscles
Strabismus/diagnosis
Strabismus/drug therapy
Esotropia/drug therapy
Botulinium toxins, type A/administration & dosage
Botulinium toxins, type A/therapeutic use
Bupivacaine/therapeutic use
Bupivacaine/administration & dosage
Injections,intramuscular
Ultrasonography
title_short Bupivacaine and botulinum toxin to treat comitant strabismus
title_full Bupivacaine and botulinum toxin to treat comitant strabismus
title_fullStr Bupivacaine and botulinum toxin to treat comitant strabismus
title_full_unstemmed Bupivacaine and botulinum toxin to treat comitant strabismus
title_sort Bupivacaine and botulinum toxin to treat comitant strabismus
author Hopker,Luisa Moreira
author_facet Hopker,Luisa Moreira
Zaupa,Priscila Fernandes
Lima Filho,Acácio Alves de Souza
Cronemberger,Monica Fialho
Tabuse,Marcia Keiko Uyeno
Nakanami,Célia Regina
Allemann,Norma
Mendonça,Tomás Scalamandré
author_role author
author2 Zaupa,Priscila Fernandes
Lima Filho,Acácio Alves de Souza
Cronemberger,Monica Fialho
Tabuse,Marcia Keiko Uyeno
Nakanami,Célia Regina
Allemann,Norma
Mendonça,Tomás Scalamandré
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Hopker,Luisa Moreira
Zaupa,Priscila Fernandes
Lima Filho,Acácio Alves de Souza
Cronemberger,Monica Fialho
Tabuse,Marcia Keiko Uyeno
Nakanami,Célia Regina
Allemann,Norma
Mendonça,Tomás Scalamandré
dc.subject.por.fl_str_mv Oculomotor muscles
Strabismus/diagnosis
Strabismus/drug therapy
Esotropia/drug therapy
Botulinium toxins, type A/administration & dosage
Botulinium toxins, type A/therapeutic use
Bupivacaine/therapeutic use
Bupivacaine/administration & dosage
Injections,intramuscular
Ultrasonography
topic Oculomotor muscles
Strabismus/diagnosis
Strabismus/drug therapy
Esotropia/drug therapy
Botulinium toxins, type A/administration & dosage
Botulinium toxins, type A/therapeutic use
Bupivacaine/therapeutic use
Bupivacaine/administration & dosage
Injections,intramuscular
Ultrasonography
description PURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection of 2 ml of 1.5% bupivacaine and 2.5 U of botulinum toxin A in agonist and antagonist muscles, respectively, of eight amblyopic eyes. Muscle thickness was measured prior and on days 1, 7 and 30 after injection using 10-MHz ultrasonography (eyelid technique). RESULTS: Mean change in alignment was 10 prism diopters after 180 days (n=6). An average increase of 1.01 mm in muscle thickness was observed after 30 days of bupivacaine injection and 0.28 mm increase was observed after botulinum toxin A injection, as measured by ultrasonography. Lateral rectus muscles injected with bupivacaine had a mean increase of 1.5 mm in muscle thickness. CONCLUSION: In this study, a change in ocular motility was observed after 180 days of intramuscular injection of bupivacaine and botulinum toxin in horizontal extraocular muscles. Overall, there was an increase of muscle thickness in both botulinum toxinum A and bupivacaine injected muscles after 30 days of injection when measured by ultrasonography. This change was more pronounced on lateral rectus muscles after bupivacaine injection.
publishDate 2012
dc.date.none.fl_str_mv 2012-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-27492012000200008
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
dc.source.none.fl_str_mv Arquivos Brasileiros de Oftalmologia v.75 n.2 2012
reponame:Arquivos brasileiros de oftalmologia (Online)
instname:Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
instname_str Conselho Brasileiro de Oftalmologia (CBO)
instacron_str CBO
institution CBO
reponame_str Arquivos brasileiros de oftalmologia (Online)
collection Arquivos brasileiros de oftalmologia (Online)
repository.name.fl_str_mv Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)
repository.mail.fl_str_mv aboonline@cbo.com.br||abo@cbo.com.br
_version_ 1754209027246522368